| Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
Variable | HR (95% CI) | P value | HR (95% CI) | P value |
Male gender | 0.97 (0.53–1.77) | 0.97 | not included | - |
Hyperlipidemia | 1.42 (0.82–2.47) | 0.21 | not included | - |
Serum creatinine, μmol/l | 1.01 (0.99–1.02) | 0.23 | not included | - |
CK-MBmax, μmol/l | 1.02 (1.01–1.03) | 0.01 | - | - |
TIMI-risk score | 1.27 (1.15–1.41) | <0.001 | - | - |
ST-segment resolution, % | 0.98 (0.97–0.99) | 0.001 | - | - |
TIMI-flow pre-PCI 0 | 1.24 (1.01–1.53) | 0.04 | - | - |
TIMI-flow post-PCI 0-II | 2.49 (1.44–4.31) | 0.001 | - | - |
LV-EFecho, % | 0.95 (0.92–0.97) | <0.001 | - | - |
Time-to-revascularization, min | 1.00 (0.99–1.01) | 0.44 | not included | - |
LV-EFCMR, % | 0.96 (0.94–0.97) | <0.001 | - | - |
Infarct size, %LV | 1.07 (1.05–1.09) | <0.001 | - | - |
MO, %LV | 1.16 (1.07–1.25) | <0.001 | - | - |
MSI | 0.93 (0.92–0.95) | <0.001 | 0.94 (0.92–0.96) | <0.001 |